A phase III, multicentre, randomised, concentration-controlled, safety and efficacy trial of voclosporin in kidney transplant patients.
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 29 Jun 2012
At a glance
- Drugs Voclosporin (Primary)
- Indications Transplant rejection
- Focus Adverse reactions; Registrational; Therapeutic Use
- 29 Jun 2012 New trial record
- 28 Jun 2012 Trial profile created following its approval by the SFDA, according to an Isotechnika Pharma media release.